Back to Stakeholders

Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals

Research, Drug Development & ManufacturingAcademic & Non-Profit Research

Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges without Dedicated Psychedelic Research Groups

Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations

Care Delivery & Psychedelic Facilitation

Research, Drug Development & Manufacturing

Medical University of Gdansk

Poland

12 Trials

The Medical University of Gdańsk is Poland's leading academic medical institution, with its Department of Psychiatry running one of the country's most active research programs on ketamine and esketamine for treatment-resistant depression and bipolar disorder.

Academic Research

0 papers

Published Papers

0

Trial Involvement

12

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type: Other
HQ: Poland
Website: Visit

Sponsored Trials

11

Not yet recruitingIII

Comparison of Intranasal Ketorolac and Intranasal Ketamine in Digital Nerve Block Pain

Start Date: December 28, 2025
Compounds: Ketamine, Placebo

Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder

Start Date: May 2, 2023
Compounds: Ketamine

Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression

Start Date: April 21, 2023

Enrolling by invitationNA

Observation of Ketamine Treatment Safety and Tolerability in Adult Psychiatry Clinic Medical University of Gdańsk Inpatients

Start Date: September 1, 2022
Compounds: Ketamine

Ketamine and Stress in OCD

Start Date: August 1, 2022
Compounds: Ketamine, Placebo

The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects

Start Date: June 1, 2022
Compounds: Ketamine, Placebo

KAP for Depression in Abstinent Opioid Users (KReDO)

Start Date: January 13, 2022
Compounds: Ketamine

Ketamine for the Treatment of Opioid Use Disorder and Depression

Start Date: December 17, 2020
Compounds: Ketamine, Placebo

Imaging Neural Correlates of Ketamine Using PET/MR

Start Date: January 10, 2020
Compounds: Esketamine, Placebo, Ketamine

A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders

Start Date: December 4, 2019
Compounds: Ketamine

Unknown statusII

Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter

Start Date: May 1, 2016
Compounds: Esketamine, Placebo, Ketamine

Collaborated Trials

1

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

Start Date: February 1, 2026
Compounds: Placebo, Ketamine